Watchlist Price Alert

VistaGen Therapeutics Inc... (VTGN)

NASDAQ: VTGN · Real-Time Price · USD

2.62

0.08 (2.95%)

At close: May 20, 2025, 3:59 PM

2.55

-2.79%

After-hours: May 20, 2025, 07:59 PM EDT

VistaGen Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Cash & Equivalents	119.17M	16.64M	68.14M	103.11M	1.36M	13.1M	10.38M	2.92M	428.5K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	726K	814.2K	569.1K	576.8K	402.9K	47.8K	47.8K	47.8K	46.9K
Receivables	n/a	n/a	n/a	40.6K	n/a	300K	n/a	n/a	n/a
Inventory	n/a	-735.6K	2.45M	942.2K	n/a	230.4K	n/a	n/a	n/a
Other Current Assets	74K	67K	2.67M	159.9K	117.9K	154.6K	556.5K	n/a	399.8K
Total Current Assets	120.67M	17.51M	71M	104.12M	1.58M	13.65M	11.02M	3.38M	855.3K
Property-Plant & Equipment	2.25M	2.77M	3.08M	3.59M	3.79M	312.7K	207.4K	286.5K	87.6K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.98M	3.58M	3.65M	4.16M	4.19M	360.5K	255.2K	334.3K	134.5K
Total Assets	123.65M	21.09M	74.64M	108.28M	5.77M	14.01M	11.28M	3.71M	989.8K
Account Payables	1.55M	2.47M	2.76M	838.3K	1.84M	1.05M	1.2M	867.3K	936K
Deferred Revenue	791K	714.3K	1.24M	1.42M	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	105K	n/a	n/a	56.5K	57.3K	53.9K	54.8K	43.6K
Other Current Liabilities	1.62M	707.4K	1.26M	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	5.12M	4.57M	5.77M	4.19M	2.77M	2.8M	1.46M	1.37M	1.79M
Long-Term Debt	n/a	2.13B	n/a	n/a	n/a	n/a	n/a	n/a	27.2K
Other Long-Term Liabilities	n/a	-2.13B	n/a	6.27M	5.01M	4.13M	2.89M	1.72M	2.15M
Total Long-Term Liabilities	4.24M	4.44M	4.16M	12.11M	8.73M	4.14M	2.9M	1.73M	2.17M
Total Liabilities	9.37M	9.01M	9.93M	16.3M	11.5M	6.94M	4.36M	3.1M	3.97M
Total Debt	2.12M	2.72M	3.04M	3.72M	4.09M	66.6K	65.8K	69.1K	71.9K
Common Stock	27K	7.3K	206.7K	180.8K	49.3K	42.8K	23.1K	9K	2.6K
Retained Earnings	-356.21M	-326.85M	-267.6M	-219.84M	-201.91M	-181.13M	-156.54M	-142M	-131.74M
Comprehensive Income	n/a	0.00	-0.00	0.00	-0.00	-4K	-4K	-4K	-6.5K
Shareholders Equity	114.29M	12.08M	64.72M	91.98M	-5.73M	7.08M	6.92M	615.8K	-2.98M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a